Novo Nordisk(MX:NVON)
MX$756.20-9.80 (-1.28%)
MX:NVON
Novo Nordisk earnings date
MX$756.20
At close:-9.80 (-1.28%)
Novo Nordisk (NVON) Q1 2026 Earnings Report
1 Followers
MX:NVON Q1 2026 EPS Results
- Actual EPS
- MXN 19.33
- Consensus EPS
- MXN 16.39
- Beat/Miss
- Beat by +MXN 2.95
- One Year Ago EPS
- MXN 18.44
MX:NVON Q1 2026 Revenue Results
- Actual Revenue
- MXN 281.06B
- Expected Revenue
- MXN 201.30B
- Beat/Miss
- Beat by +MXN 79.76B
- YoY Revenue Growth
- +37.63%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/06/2026
- Time
- Before Open
- Conference Call
- Wednesday, May 6, 2026
MX:NVON Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:NVON Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVON Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.27- | 17.68 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.5516.13 | 12.83 | 25.72% (+3.30) | |
| Aug 04, 2026 | 2026 (Q2) | 14.2717.70 | 17.22 | 2.80% (+0.48) | |
| May 06, 2026 | 2026 (Q1) | 16.3919.33 | 18.44 | 4.82% (+0.89) | |
| Feb 04, 2026 | 2025 (Q4) | 17.1117.68 | 16.42 | 7.67% (+1.26) | |
| Nov 05, 2025 | 2025 (Q3) | 14.1612.83 | 16.33 | -21.45% (-3.50) | |
| Aug 06, 2025 | 2025 (Q2) | 17.0317.22 | 12.2 | 41.19% (+5.02) | |
| May 07, 2025 | 2025 (Q1) | 16.9618.44 | 15.09 | 22.24% (+3.36) | |
| Feb 05, 2025 | 2024 (Q4) | 15.4016.42 | 13.27 | 23.74% (+3.15) | |
| Nov 06, 2024 | 2024 (Q3) | 16.3116.33 | 13.18 | 23.91% (+3.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
